It is a pharma private limited company based in New Delhi, Delhi, India, established in 2004.
2004 | New Delhi, Delhi, India | AmalgamatedUmesh Pharmaceuticals Private Limited, a amalgamated private limited company, was established on 03 August 2004 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232DL2004PTC128051. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹7.50 M and a paid-up capital of ₹7.41 M.
It upholds a compliant status. Its leadership includes Prabhat Kumar Srivastava (Director), Riya Srivastava (Director). Past directors included Prabhat Kumar Srivastava, Riya Srivastava, Pinka Sharma. Its latest AGM occurred on 25 September 2021, with the balance sheet filed on 31 March 2021. It is based at C-30, Panchsheel Enclave, New Delhi, Delhi, 110017.
U24232DL2004PTC128051
128051
03 August 2004
₹7.50 M
₹7.41 M
Roc Delhi
Unlisted
Amalgamated
Explore comprehensive insights into Umesh Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prabhat Kumar Srivastava | Director | 13 Sep 2018 | Current |
| Riya Srivastava | Director | 23 Feb 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2012 | Past |
| Pramod Abcsdd | Director | 23 Feb 2012 | Past |
| Pramod Abcsdd | Director | 15 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Umesh Pharmaceuticals Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 13.06% decrease in profit. The company's net worth dipped by a decrease of 0.03%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
In 2018, Umesh Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Umesh Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Umesh Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Umesh Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Umesh Pharmaceuticals Private Limited last Annual general meeting of members was held on 25 Sep 2021 as per latest MCA records. was documented.
Progress on Umesh Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Delhi. was documented.
Progress on Prabhat Kumar Srivastava was appointed as a Director was appointed as a Director on 13 Sep 2018 & has been associated with this company since 7 years 2 months . was documented.
Progress on Riya Srivastava was appointed as a Director was appointed as a Director on 23 Feb 2012 & has been associated with this company since 13 years 9 months . was documented.
Progress on Umesh Pharmaceuticals Private Limited was registered on 03 Aug 2004 with Roc Delhi & aged 21 years 3 months as per MCA records. was documented.
The CIN of Umesh Pharmaceuticals Private Limited is U24232DL2004PTC128051.
Umesh Pharmaceuticals Private Limited is headquartered at C-30, Panchsheel Enclave, New Delhi, Delhi, 110017.
Umesh Pharmaceuticals Private Limited was incorporated on 03 August 2004.
The current directors of Umesh Pharmaceuticals Private Limited are
The primary industry of Umesh Pharmaceuticals Private Limited is Manufacturing.
Umesh Pharmaceuticals Private Limited is unlisted.
The authorized capital of Umesh Pharmaceuticals Private Limited is ₹7.50 M, and the paid-up capital is ₹7.41 M.
The compliance status of Umesh Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX